Dianthus Therapeutics (DNTH) Misses Q4 EPS by 143c
Tweet
Share
E-mailGet Alerts DNTH Hot Sheet
Join SI Premium – FREE
Dianthus Therapeutics (NASDAQ: DNTH) reported Q4 EPS of ($1.43). Revenue for the quarter came in at $280 thousand.
For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- salesforce.com (CRM) Reiterated Market Outperform by Citizens: 50% of Checks Positive
- Piper Sandler Starts Agomab Therapeutics (AGMB) at Overweight
- UBS Upgrades Fluence Energy Inc. (FLNC) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
